|
pubmed:abstractText |
Artemisinin and its derivatives are already registered and available in some east Asian countries, and will soon become so in some countries in Africa. Regulatory mechanisms need to be strengthened in tropical countries to ensure the quality, safety and efficacy of these valuable drugs. Steps also need to be taken to improve dissemination of scientific information. A consensus has been reached internationally on the role of artemisinin and its derivatives in the current treatment of malaria, and guidelines drawn up. Post-registration surveillance is needed to monitor, at country level, drug efficacy, safety, and quality.
|
